Kiribati vs Macau, China: Treatment success rate for patients treated for MDR-TB
Kiribati
100.0%
in 2022
Macau, China
100.0%
in 2022
Kiribati rank
1st
Macau, China rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Kiribati
- Macau, China
How they compare
Kiribati currently reports 100.0% against 100.0% in Macau, China, a difference of 0.0%.
The two have swapped places 3 times across 6 shared years of data; in 2015 it was Kiribati ahead.
Kiribati ranks 1st and Macau, China ranks 1st of 163 countries.
Kiribati has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kiribati | Macau, China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100.0% | 71.0% | 29.0% | Kiribati |
| 2020s | 91.5% | 87.5% | 4.0% | Kiribati |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Kiribati or Macau, China?
- Kiribati, at 100.0% against 100.0% in Macau, China as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Kiribati and Macau, China?
- 0.0%, with Kiribati ahead.
- How many years of comparable data are there for Kiribati and Macau, China?
- 6 years are reported by both, from 2015 to 2022.
- How do Kiribati and Macau, China rank globally for treatment success rate for patients treated for mdr-tb?
- Kiribati ranks 1st and Macau, China ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.